| 000 | 01702 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250514060539.0 | ||
| 264 | 0 | _c20030528 | |
| 008 | 200305s 0 0 eng d | ||
| 022 | _a1120-009X | ||
| 024 | 7 |
_a10.1179/joc.2002.14.6.597 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGrassi, C | |
| 245 | 0 | 0 |
_aEfficacy and safety of short course (5-day) moxifloxacin vs 7-day ceftriaxone in the treatment of acute exacerbations of chronic bronchitis (AECB). _h[electronic resource] |
| 260 |
_bJournal of chemotherapy (Florence, Italy) _cDec 2002 |
||
| 300 |
_a597-608 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase IV; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Infective Agents _xadministration & dosage |
| 650 | 0 | 4 | _aAza Compounds |
| 650 | 0 | 4 |
_aBronchitis, Chronic _xdrug therapy |
| 650 | 0 | 4 |
_aCeftriaxone _xadministration & dosage |
| 650 | 0 | 4 | _aCosts and Cost Analysis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFluoroquinolones |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aItaly |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMoxifloxacin |
| 650 | 0 | 4 |
_aNational Health Programs _xeconomics |
| 650 | 0 | 4 | _aQuinolines |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aCasali, L | |
| 700 | 1 | _aCurti, E | |
| 700 | 1 | _aTellarini, M | |
| 700 | 1 | _aLazzaro, C | |
| 700 | 1 | _aSchito, G | |
| 773 | 0 |
_tJournal of chemotherapy (Florence, Italy) _gvol. 14 _gno. 6 _gp. 597-608 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1179/joc.2002.14.6.597 _zAvailable from publisher's website |
| 999 |
_c12381024 _d12381024 |
||